Jeff Cummings, MD, ScD

Pimavanserin Significantly Reduces Risk of Relapse of Dementia-related Psychosis: Results From the Double-Blind Phase of the HARMONY Study

Patients with dementia often experience dementia-related psychosis (DRP), which is associated with adverse outcomes and has no approved therapy in the US. Pimavanserin is a selective sero...

Srdjan Stankovic , MD, MSPH;

Erin Foff , MD, PhD;

Bradley McEvoy , DrPH, MSc;

Jeff Cummings , MD, ScD;

Maria-Eugenia Soto-Martin , MD;

Pierre Tariot , MD;

10/08/2020

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Jeff Cummings, MD, ScD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products